Thyrocare Technologies Ltd (THYROCARE) Q4FY26 Management Mirror - Mar-2026 Qtr
Revenue and Volume Outlook
In the Dec'25 Qtr, management projected sustainable consolidated revenue growth of 15% to 16%, driven by 12% to 15% growth in the franchise business and partnership growth at 1.5x the franchise rate, while also noting that Vimta revenues had bottomed out; however, all forward-looking guidance was suspended in the Mar'26 Qtr as the earnings call was cancelled. [Status: Withdrawn]
3 more themes on the ELITE plan.